I only came this but pure chance was looking at the clinical pipelines of other biotechs.
but what was interesting was the Mechanism of action. NUZ has a promising ALs treatment that using Mtor and TDP43 target and exploring AD as a result.
Also, Race has an FTO inhibitor (only one in the world currently in the clinic) which fights cancer and is cardio and organ protective against ROS allegedly.
Thought that IXC results were interesting but perhaps a few years behind, as merely exploratory.
I only came this but pure chance was looking at the clinical...
Add to My Watchlist
What is My Watchlist?
